Connect with us

Science

Personalized Immunotherapy Response Studied in Body-on-a-Chip Cancer Models – Newswise

Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform…

Published

on

Article feature image

Newswise — WINSTON-SALEM, NC, JULY 19, 2021 — Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one of the rarest…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending